Skip to main content

Table 2 Prevalence of Blastocystis and subtypes, gut intestinal in FACSA and UNEME cohort

From: Prevalence of Blastocystis and its association with Firmicutes/Bacteroidetes ratio in clinically healthy and metabolically ill subjects

  Total FACSA UNEME
Blastocystis, n (%). 153 (52.46) 94 (47.0) 55 (65.48)*
 Subtype 1 (ST1) 22 (14.86) 14 (14.89) 8 (14.81)
 Subtype 2 (ST2) 14 (8.78) 8 (8.51) 5 (9.26)
 Subtype 3 (ST3) 42 (28.38) 28 (29.79) 14 (25.93)
 Subtype 4(ST4) 21 (14.19) 16 (17.02) 5 (9.26)
 Subtype 5 (ST5) 21 (14.19) 5 (5.32) 16 (29.63)*
 Subtype 7 (ST7) 21 (14.19) 12 (12.77) 9 (16.67)
Gut microbiota
 RAUF, Median IR 1.07 (0.23–2.35) 0.80 (0.05–2.08) 1.92 (0.71–3.53)*
 RAUB, Median IR 0.96 (0.47–2.11) 0.82 (0.44–1.65) 1.16 (0.63–3.29)*
F/B ratio, Median IR 0.95 (0.22–3.50) 0.83 (0.07–3.50) 1.40 (0.32–4.03)*
  1. n Number, (%) Percentage, IR Interquartile range, RAUF Relative abundance units Firmicutes, RAUB Relative abundance units Bacteroidetes, F/B ratio Firmicutes/Bacteroidetes ratio. x2, Mann-Whitney-Wilcoxon
  2. * p < 0.05